Back to Search
Start Over
Mitogen-Activated Protein Kinases Mediate Adventitial Fibroblast Activation and Neointima Formation via GATA4/Cyclin D1 Axis.
- Source :
-
Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2024 Jun; Vol. 38 (3), pp. 527-538. Date of Electronic Publication: 2023 Jan 18. - Publication Year :
- 2024
-
Abstract
- Purpose: Activation of mitogen-activated protein kinases (MAPKs) by pathological stimuli participates in cardiovascular diseases. Dysfunction of adventitial fibroblast has emerged as a critical regulator in vascular remodeling, while the potential mechanism remains unclear. In this study, we sought to determine the effect of different activation of MAPKs in adventitial fibroblast contributing to neointima formation.<br />Methods: Balloon injury procedure was performed in male 12-week-old Sprague-Dawley rats. After injury, MAPK inhibitors were applied to the adventitia of injured arteries to suppress MAPK activation. Adventitial fibroblasts were stimulated by platelet-derived growth factor-BB (PDGF-BB) with or without MAPK inhibitors. RNA sequencing was performed to investigate the change of pathway and cell function. Wound healing, transwell assay, and flow cytometry were used to analyze adventitial fibroblast function.<br />Results: Phosphorylation of p38, c-Jun N-terminal kinase (JNK), and extracellular regulated kinases 1/2 (ERK1/2) was increased in injured arteries after balloon injury. In primary culture of adventitial fibroblasts, PDGF-BB increased phosphorylation of p38, JNK, ERK1/2, and extracellular regulated kinase 5 (ERK5) in a short time, which was normalized by their inhibitors respectively. Compared with the injury group, perivascular administration of four MAPK inhibitors significantly attenuated neointima formation by quantitative analysis of neointimal area, intima to media (I/M) ratio, and lumen area. RNA sequencing of adventitial fibroblasts treated with PDGF-BB with or without four inhibitors demonstrated differentially expressed genes involved in multiple biological processes, including cell adhesion, proliferation, migration, and inflammatory response. Wound healing and transwell assays showed that four inhibitors suppressed PDGF-BB-induced adventitial fibroblast migration. Cell cycle analysis by flow cytometry demonstrated that JNK, ERK1/2, and ERK5 but not p38 inhibitor blocked PDGF-BB-induced G1 phase release associated with decrease expression of cell cycle protein Cyclin D1 and transcription factor GATA4. Moreover, four inhibitors decreased macrophage infiltration into adventitia and monocyte chemoattractant protein-1 (MCP-1) expression.<br />Conclusion: These results suggest that MAPKs differentially regulate activation of adventitial fibroblast through GATA4/Cyclin D1 axis that participates in neointima formation.<br /> (© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Subjects :
- Animals
Male
Rats
Angioplasty, Balloon adverse effects
Carotid Artery Injuries pathology
Carotid Artery Injuries enzymology
Carotid Artery Injuries drug therapy
Carotid Artery Injuries metabolism
Cell Movement drug effects
Cell Proliferation drug effects
Cells, Cultured
Disease Models, Animal
Phosphorylation
Protein Kinase Inhibitors pharmacology
Rats, Sprague-Dawley
Signal Transduction
Vascular System Injuries pathology
Vascular System Injuries enzymology
Vascular System Injuries metabolism
Vascular System Injuries drug therapy
Adventitia pathology
Adventitia drug effects
Adventitia metabolism
Adventitia enzymology
Becaplermin pharmacology
Cyclin D1 metabolism
Cyclin D1 genetics
Fibroblasts drug effects
Fibroblasts pathology
Fibroblasts metabolism
Fibroblasts enzymology
Mitogen-Activated Protein Kinases metabolism
Neointima
Subjects
Details
- Language :
- English
- ISSN :
- 1573-7241
- Volume :
- 38
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Cardiovascular drugs and therapy
- Publication Type :
- Academic Journal
- Accession number :
- 36652042
- Full Text :
- https://doi.org/10.1007/s10557-023-07428-1